期刊论文详细信息
Pathology & Oncology Research
Malignancies after renal transplantation during 33 years at a single center
Ferenc Perner2  Maria Tóth1  Gyula Végső2  Robert Mlanger2  András Tóth2  Éva Toronyi2  Jenő Járay2  Elek Dinya1  Márta Hídvégi2 
[1] EGIS Pharmaceutical PLC$$;Semmelweis University$$
关键词: waiting list;   
DOI  :  10.1007/BF02893443
学科分类:生理学与病理学
来源: Springer
PDF
【 摘 要 】

This study provides an analysis of incidence and characteristics of malignant tumors of 2535 patients who underwent renal transplantation between 1973 and 2007 at the Transplantation Center in Budapest. One hundred ninety-three malignant diseases were found in 188 patients (7.6%). The incidence of thyroid-, renal-hepatic-, skin- and gastric cancers as well as of Kaposi sarcoma and lymphomas increased in our transplant patient cohort compared to the figures of the general population based on the data of our Cancer Registry. On the other hand, colorectal-, oralprostate and lung cancers were underrepresented in our patient cohort. The mean time of diagnosis of malignancies following kidney transplantation was 58.5± 44.8 months. One fifth of the tumors were detected within the first year. Patients with malignancies were distributed into four groups based on the immunosuppressive regimen: group I (8.5%), azathioprine + prednisone; group II (59.0%), cyclosporine + prednisone; group III (26.6%), cyclosporine + mycophenolate mofetil + prednisone; group IV (5.9%), tacrolimus + mycophenolate mofetil + prednisone. The mean age of patients was 47.3, 53.5, 55.5 and 58.1 years in group I, II, III and IV, respectively. Oncologic and immunosuppressive therapy was decided individually. Immunosuppression was switched to rapamycin-containing regimens in 63 cases. We lost 92 patients (48.9%) with a mean survival time of 25.8± 39.4 months. Cumulative 1- and 5-year survivals were 69.5% and 52%, respectively. The increasing number of cancers seen early after transplantation and the increased risk of developing a cancer due to the older age of recipients draw attention to the importance of regular oncologic screening in patients on the waiting list and after transplantation.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912040504862ZK.pdf 85KB PDF download
  文献评价指标  
  下载次数:18次 浏览次数:7次